Gynecology Oncology MDC

Patients diagnosed with cervical cancer, uterine cancer, vaginal cancer, vulvar cancer and ovarian cancer receive treatment through the gynecology oncology multidisciplinary clinic (MDC) at KHCC.
Cancer patients who need hormone replacement and prophylactics for osteoporosis also benefit from this clinic. Patients are either self-referred, referred through their treating physicians or through the screening clinic at KHCC.
Once the patient is accepted, their case is presented to the rest of the multidisciplinary team and their pathology slides and radiology images are reviewed. Treatment options are then discussed and relayed to the patient by the attending physician. Patients who are potential candidates for radiation therapy or chemo-radiation are seen and examined by a medical oncologist and radiation oncologist for final disposition and discussion of treatment. Patients who are candidates for surgery are seen by a surgeon. In addition, patients who need pain management, physical therapy, psychosocial services or nutrition services are referred accordingly. 
Patients receiving treatment through the gynecology MDC usually receive at least one or a combination of the following treatment options (depending on the nature of their disease):
  • Surgery (open and laparoscopic approach)
  • Radiotherapy (external beam using three-dimensional and intensity modulated radiotherapy)
  • High-dose brachytherapy (Intracavitary brachytherapy using high-dose rate Ir-192 micro-selectron is only available at KHCC)
  • Chemotherapy
  • Hormone therapy.

Who’s on the MDC team? 
Dr. Imad Jaradat – Head of Gynecology Oncology MDC
Dr. Ghadeer Abdeen
Dr. Laila Abu Tahoun
Dr. Osama Badran
The team meets weekly to review all cases on the MDC list.
Ancillary and patient support services
The gynecology oncology MDC works in close cooperation with the pain management department, nutritionists, physical therapists and psychosocial services at KHCC in order to provide patients with the most comprehensive care possible.